2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

MAY 23 Sessions Monday morning 8:00 AM – 10:00 AM • East Ballroom • Third Floor 2 New Insights into the Role of Uric Acid in Hypertension Co-Chairs: Richard J. Johnson, MD, Denver, CO and Andrew Whelton, MD, Baltimore, MD 8:00 AM Fructose-Obesity-Uric Acid Link Richard J. Johnson, MD 8:25 AM Oxidative Stress and Impact of Uric Acid Allan D. Struthers, MD, Dundee, United Kingdom 8:40 AM Urate-Lowering and Blood Pressure Response Daniel I. Feig, MD, PhD, Houston, TX Original Communications 9:00 AM OR-18: Associations of Uric Acid with Asymmetric Dimethylarginine, L-arginine and Arterial Stiffening in Hypertension K. Dimitriadis, C. Tsioufis, A. Aggelis, S. Kyvelou, E. Stefanadi, L. Lioni, D. Flessas, C. Stefanadis. Hippokration Hospital, Athens, GR. 9:15 AM OR-19: Epoxyeicosatrienoic Acid Agonist Attenuates Adipogenesis Derived from Mesenchymal Stem Cells Via Heme Oxygenase-PPARg Pathways DongHyun Kim, 1 Luca Vanella, 1 Nitin Puri, 1 Michal L. Schwartzman, 2 John R. Falck, 3 Komal Sodhi, 1 Nader G. Abraham. 1 1 University of Toledo College of Medicine, Toledo, OH, US; 2 New York Medical College, Valhalla, NY, US; 3 University of Texas Southwestern Medical Center, Dallas, TX, US. 9:30 AM OR-20: Effect of Allopurinol on Blood Pressure: A Systematic Review Vikram Agarwal, 1 Nidhi Hans, 2 Franz Messerli. 1 1 St. Luke’s-Roosevelt Hospital Center, NY, US; 2 Harvard School of Public Health, MA, US. 1 Pathobiology Track 2 Translational Track 3 Therapy Track 66
Monday Morning MAY 23 Sessions 8:00 AM – 10:00 AM • West Ballroom • Third Floor 3 Devices and Surgical Ablation for Refractory Hypertension Co-Chairs: Domenic A. Sica, MD, Richmond, VA and Ronald G. Victor, MD, Los Angeles, CA 8:00 AM How to Evaluate and Choose the Appropriate Patient Henry Krum, MBBS, PhD, Melbourne, Australia 8:20 AM Renal Nerve Ablation Roland E. Schmieder, MD, Erlangen, Germany 8:40 AM Carotid Baroreceptor Manipulation John D. Bisognano, MD, PhD, FASH, Rochester, NY Original Communications 9:00 AM OR-21: True Resistant Hypertension: Optimal Cut- Off Ambulatory Blood Pressure Level for Diagnosis and Effect of Spironolactone Jose A. Garcia‐Donaire, Julian Segura, Cesar Cerezo, Luis M. Ruilope. Hospital 12 de Octubre, Madrid, ES. 9:15 AM OR-22: Individualized Programming Demonstrates Feasibility of Unilateral Approach to Delivery of Baroreflex Activation Therapy® Domenic Sica†, 1 John Bisognano, 2 Mitra Nadim, 3 Luis Sanchez, 4 George Bakris. 5 1 Virginia Commonwealth University, Richmond, VA, US; 2 University of Rochester, Rochester, NY, US; 3 University of Southern California, Los Angeles, CA, US; 4 Washington University, St. Louis, MO, US; 5 University of Chicago, Chicago, IL, US. 9:30 AM OR-23: The Efficacy of Adding the Direct Renin Inhibitor Aliskiren on the Patients with Resistant Hypertension (55% Had Chronic Kidney Disease) – Subgroup Analysis on Different Levels of Plasma Renin Activity Fumitoshi Satoh, Ryo Morimoto, Masataka Kudo, Yoshitugu Iwakura, Yoshikiyo Ono, Sadayoshi Ito. Tohoku University Hospital, Sendai, JP 9:45 AM OR-24: Exploring the Prevalence of Resistant Hypertension in a Large Ethnically Diverse Hypertensive Population Simran Bhandari, In Lu Liu, Jiaxiao Shi, Federico Calara, Scott Rasgon, John Sim. Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, US. 1 Pathobiology Track 2 Translational Track 3 Therapy Track 67
Page 1 and 2:
American Society of Hypertension, I
Page 3:
Visit booth #1100 to find out more
Page 6 and 7:
Past Presidents of the American Soc
Page 8 and 9:
Program Color Key The pages of this
Page 10 and 11:
Letter continued Following the Awar
Page 12 and 13:
General Information continued Discl
Page 14 and 15:
General Information continued ASH S
Page 16 and 17:
General Information continued ASH P
Page 18 and 19: 2011 ASH Corporate Members Boehring
Page 20 and 21: ASH Leadership 2010-2011 Board of D
Page 22 and 23: Special Lecture Monday, May 23, 201
Page 24 and 25: Young Scholar Award* Monday, May 23
Page 26 and 27: Special Lecture Monday, May 23, 201
Page 28 and 29: 2011 Abstract Reviewers Lawrence J.
Page 30 and 31: More than half of hypertensive pati
Page 32 and 33: Poster Category Presentation Poster
Page 34 and 35: 2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37: 2011 ASH Faculty continued David L.
Page 38 and 39: American Society of Hypertension, I
Page 40 and 41: Program Color Key The pages of this
Page 42 and 43: MAY 21 Saturday Morning Hypertensio
Page 44 and 45: MAY 21 Sessions Saturday Afternoon
Page 50 and 51: MAY 21 Posters Saturday Evening Pos
Page 52 and 53: MAY 22 Sunday morning Sessions cont
Page 54 and 55: MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57: MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59: MAY 22 Debates Sunday Morning 11:00
Page 60 and 61: MAY 22 Plenary Session I Sunday Aft
Page 62 and 63: MAY 22 Special Sessions Sunday Afte
Page 64 and 65: MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67: MAY 23 Satellite Symposium 6:00 AM
Page 70 and 71: MAY 23 Sessions Monday morning 8:30
Page 78 and 79: MAY 23 Plenary Session II Monday Af
Page 80 and 81: MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83: MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85: MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88: 2011 American Society of Hypertensi
Page 89 and 90: Saturday Afternoon MAY 21 Posters 4
Page 91 and 92: Saturday Afternoon MAY 21 Posters P
Page 93 and 94: Saturday Afternoon MAY 21 Posters E
Page 99 and 100: Saturday Afternoon MAY 21 Posters I
Page 107 and 108: Sunday Morning MAY 22 Posters 10:00
Page 109 and 110: Sunday Morning MAY 22 Posters 10:00
Page 111 and 112: Sunday Morning MAY 22 Posters PO-13
Page 119 and 120:
Sunday Morning MAY 22 Posters PO-19
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Monday Morning Afternoon MAY 21 23
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Faculty Disclosure Listing Rajiv Ag
Page 149 and 150:
Faculty Disclosure Listing continue
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
ASH Hypertension Resource Pavilion
Page 159 and 160:
2011 ASH Innovations Theater Rhinel
Page 161 and 162:
2011 ASH Exhibitors continued A & D
Page 163 and 164:
2011 ASH Exhibitors continued David
Page 165 and 166:
2011 ASH Exhibitors continued Inter
Page 167 and 168:
2011 ASH Exhibitors continued Novar
Page 169 and 170:
2011 ASH Exhibitors continued Wiley
Page 171 and 172:
Author Index Berezina, Aelita V., 8
Page 173 and 174:
Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176:
Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178:
Author Index Makani, Harikrishna, 1
Page 179 and 180:
Author Index Rabelink, Ton J., 93 R
Page 181 and 182:
Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184:
Hilton New York Floor Plans Second
Page 185 and 186:
Hilton New York Floor Plans Fourth
Page 187 and 188:
Tekamlo (aliskiren and amlodipine)
Page 189 and 190:
25% (systolic) and 27% (diastolic)
Page 191 and 192:
Two cases of angioedema with respir
Page 193 and 194:
amlodipine and sildenafil were used
Page 195 and 196:
Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

Create successful ePaper yourself

Delete template?

Save as template?